| Literature DB >> 26179085 |
Natalia Pawlas1, Michał Dobrakowski2, Aleksandra Kasperczyk2, Agnieszka Kozłowska1, Agnieszka Mikołajczyk1, Sławomir Kasperczyk3.
Abstract
The possible beneficial role of selenium (Se) on the oxidative stress induced by lead (Pb) is still unclear in humans. Therefore, the aim of the present study was to explore the associations among the Se levels, chronic Pb exposure, oxidative stress parameters, and parameters characterizing the function of the antioxidant defense system in men who are occupationally exposed to Pb. Based on the median serum Se concentrations, the 324 study subjects were divided into two subgroups: a subgroup with a low Se level (L-Se) and a subgroup with a high Se level (H-Se). The levels of lead (PbB) and zinc protoporphyrin (ZPP) in the blood and the delta-aminolevulinic acid (ALA) level in the urine served as indices of Pb exposure. The PbB level was significantly lower in the H-Se group compared to that in the L-Se group by 6 %. The levels of 8-hydroxyguanosine and lipofuscin (LPS) and the activity of superoxide dismutase were significantly lower in the H-Se group compared to that in the L-Se group by 17, 19, and 11 %, respectively. However, the glutathione level (GSH) and the activities of glutathione peroxidase (GPx) and catalase were significantly higher by 9, 23, and 3 %. Spearman correlations showed positive associations between the Se level and GPx activity and GSH level. A lower serum Se level in chronically Pb-exposed subjects is associated with higher Pb blood levels and an elevated erythrocyte LPS level, which reflects the intensity of oxidative stress. Besides, in a group of Pb-exposed subjects with lower serum Se level, depleted GSH pool and decreased activity of GPx in erythrocytes were reported. However, the present results are inadequate to recommend Se supplementation for chronic lead exposure at higher doses than would be included in a normal diet except for selenium deficiency.Entities:
Keywords: Antioxidant defense system; Glutathione peroxidase; Lead poisoning; Oxidative stress; Selenium
Mesh:
Substances:
Year: 2015 PMID: 26179085 PMCID: PMC4744245 DOI: 10.1007/s12011-015-0435-z
Source DB: PubMed Journal: Biol Trace Elem Res ISSN: 0163-4984 Impact factor: 3.738
Epidemiologic parameters and the blood lead level (PbB), mean, maximum and minimum PbB, zinc protoporphyrin concentration in blood (ZPP) mean, maximum and minimum ZPP and delta-aminolevulinic acid (ALA) in urine
| Low Se group | High Se group | Relative change (%) |
| |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| Age | 39.0 | 11.0 | 38.0 | 9.78 | −2 | 0.418 |
| Years of work | 13.7 | 11.4 | 12.0 | 10.4 | −13 | 0.157 |
| Height (cm) | 176 | 6.32 | 176 | 5.83 | 0 | 0.608 |
| Weight (kg) | 83.8 | 14.8 | 85.4 | 12.4 | 2 | 0.308 |
| Systolic blood pressure (mmHg) | 121.91 | 5.52 | 121.17 | 5.42 | −1 | 0.058 |
| Diastolic blood pressure (mmHg) | 78.52 | 4.66 | 78.09 | 4.93 | −1 | 0.418 |
| PbB (μg/dl) | 33.83 | 9.43 | 31.85 | 9.87 | −6 | 0.030 |
| PbBmean (μg/dl) | 32.55 | 8.86 | 30.87 | 9.22 | −5 | 0.069 |
| PbBmin (μg/dl) | 20.12 | 9.71 | 19.20 | 9.42 | −5 | 0.397 |
| PbBmax (μg/dl) | 43.18 | 11.47 | 41.45 | 12.12 | −4 | 0.087 |
| ZPP (μg/g Hb) | 4.28 | 2.25 | 4.05 | 1.90 | −5 | 0.324 |
| ZPPmean (μg/g Hb) | 4.81 | 2.38 | 4.50 | 2.26 | −6 | 0.237 |
| ZPPmin (μg/g Hb) | 2.87 | 1.52 | 2.77 | 1.19 | −4 | 0.512 |
| ZPPmax (μg/g Hb) | 7.89 | 4.72 | 7.36 | 5.00 | −7 | 0.089 |
| ALA (mg/l) | 5.38 | 1.73 | 4.77 | 1.95 | −11 | 0.386 |
PbB and ZPP mean levels of Pb and ZPP in the blood determined simultaneously with the biochemical analysis; PbB and ZPP mean levels of Pb and ZPP in the blood calculated based on the values determined, on average, every 3 months during the 5 years of observation before the study; PbB , PbB , ZPP , and ZPP mean of the maximal and minimal levels of Pb and ZPP in the blood collected from each worker calculated based on the values determined, on average, every 3 months during the 5 years of observation
Epidemiologic parameters in study population
| Low Se group (%) | High Se group (%) |
| |
|---|---|---|---|
| Smokers | 42 | 34 | 0.138 |
| Coronary heart disease | 2 | 3 | 0.476 |
| Hypertension | 9 | 10 | 0.711 |
| Diabetes | 2 | 4 | 0.522 |
Fig. 1The concentration of selenium (Se) in serum, blood lead level (PbB), 8-hydroxydeoxyguanosine (8-OHdG) in urine, lipofuscin (LPS) in erythrocytes, the activity of glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD) in erythrocytes and erythrocyte glutathione (GSH) concentration expressed as a percentage of the mean baseline values in low Se group. Data are presented as a mean and SEM. *p < 0.05, **p < 0.01, ***p < 0.001—comparison between the low and high Se groups
Concentration of selenium and parameters related to oxidative stress intensity and antioxidant reserves in blood and urine
| Low Se group | High Se group | Relative change (%) |
| |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| Se (μg/l) in serum | 57.9 | 8.62 | 90.1 | 15.6 | 56 | <0.001 |
| TAC (mmol/l) in serum | 0.90 | 0.14 | 0.92 | 0.13 | 3 | 0.123 |
| TOS (μmol/l) in serum | 13.4 | 15.1 | 12.0 | 6.50 | −11 | 0.268 |
| LPH (μmol/l) in serum | 4.47 | 6.07 | 4.93 | 3.13 | 10 | 0.400 |
| MDA (μmol/l) in serum | 2.48 | 1.06 | 2.39 | 1.09 | −3 | 0.469 |
| 8OHdG (ng/g creatinine) in urine | 13.3 | 11.73 | 11.0 | 7.23 | −17 | 0.039 |
| LPS (RF/dl) in erythrocytes | 19.2 | 9.60 | 15.6 | 9.49 | −19 | <0.001 |
| GPx (U/gHb) in erythrocytes | 51.2 | 27.37 | 62.9 | 26.8 | 23 | <0.001 |
| GR (U/g Hb) in erythrocytes | 4.59 | 1.94 | 4.51 | 1.63 | −2 | 0.671 |
| CAT (kU/g Hb) in erythrocytes | 435 | 59.0 | 450 | 57.4 | 3 | 0.023 |
| SOD (NU/mg Hb) in erythrocytes | 10.6 | 2.68 | 9.40 | 2.37 | −11 | <0.001 |
| GSH (μmol/g Hb) in erythrocytes | 3.44 | 1.09 | 3.75 | 1.16 | 9 | 0.006 |
Correlations between selenium and the blood lead level (PbB), mean, maximum, minimum PbB, zinc protoporphyrin concentration in blood (ZPP) mean, maximum, minimum ZPP, and parameters related to oxidative stress intensity and antioxidant reserves in blood and urine (Spearman R coefficient)
|
|
| |
|---|---|---|
| Se and PbB |
| 0.019 |
| Se and PbBmean |
| 0.026 |
| Se and PbBmin | −0.09 | 0.113 |
| Se and PbBmax |
| 0.013 |
| Se and ZPP | −0.02 | 0.768 |
| Se and ZPPmean | −0.08 | 0.172 |
| Se and ZPPmax | −0.09 | 0.110 |
| Se and ZPPmin | −0.03 | 0.573 |
| Se and TAC | 0.07 | 0.185 |
| Se and TOS | −0.02 | 0.721 |
| Se and LPH | 0.14 | 0.013 |
| Se and MDA | −0.07 | 0.197 |
| Se and LPS |
|
|
| Se and 8OHdG | −0.09 | 0.111 |
| Se and GPx | 0.32 |
|
| Se and GR | 0.04 | 0.447 |
| Se and CAT | 0.12 | 0.025 |
| Se and SOD |
|
|
| Se and GSH | 0.12 | 0.035 |